414 related articles for article (PubMed ID: 27461582)
1. Modifiable and non-modifiable risk factors for pancreatic cancer: A review.
Midha S; Chawla S; Garg PK
Cancer Lett; 2016 Oct; 381(1):269-77. PubMed ID: 27461582
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
Becker AE; Hernandez YG; Frucht H; Lucas AL
World J Gastroenterol; 2014 Aug; 20(32):11182-98. PubMed ID: 25170203
[TBL] [Abstract][Full Text] [Related]
3. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.
Pang Y; Holmes MV; Chen Z; Kartsonaki C
J Gastroenterol Hepatol; 2019 Feb; 34(2):330-345. PubMed ID: 30550622
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
[TBL] [Abstract][Full Text] [Related]
5. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Cancer: A Review.
Yabar CS; Winter JM
Gastroenterol Clin North Am; 2016 Sep; 45(3):429-45. PubMed ID: 27546841
[TBL] [Abstract][Full Text] [Related]
7. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.
Yeo TP
Semin Oncol; 2015 Feb; 42(1):8-18. PubMed ID: 25726048
[TBL] [Abstract][Full Text] [Related]
8. Familial pancreatic cancer.
Rieder H; Bartsch DK
Fam Cancer; 2004; 3(1):69-74. PubMed ID: 15131409
[TBL] [Abstract][Full Text] [Related]
9. Familial Pancreatic Ductal Adenocarcinoma.
Diaz KE; Lucas AL
Am J Pathol; 2019 Jan; 189(1):36-43. PubMed ID: 30558720
[TBL] [Abstract][Full Text] [Related]
10. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.
Andersen DK; Korc M; Petersen GM; Eibl G; Li D; Rickels MR; Chari ST; Abbruzzese JL
Diabetes; 2017 May; 66(5):1103-1110. PubMed ID: 28507210
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with pancreatic cancer in Spain. What can we learn from epidemiological studies?
Marra-López Valenciano C
Rev Esp Enferm Dig; 2022 Aug; 114(8):445-447. PubMed ID: 35704373
[TBL] [Abstract][Full Text] [Related]
12. Association between chronic pancreatitis and pancreatic cancer: A 10-year retrospective study of endoscopically treated and surgical patients.
Korpela T; Udd M; Mustonen H; Ristimäki A; Haglund C; Seppänen H; Kylänpää L
Int J Cancer; 2020 Sep; 147(5):1450-1460. PubMed ID: 32162688
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.
Klein AP
Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):493-502. PubMed ID: 34002083
[TBL] [Abstract][Full Text] [Related]
14. Current Approaches to Pancreatic Cancer Screening.
Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ
Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719
[TBL] [Abstract][Full Text] [Related]
15. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
16. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
17. Demographics and epidemiology of pancreatic cancer.
Yeo TP; Lowenfels AB
Cancer J; 2012; 18(6):477-84. PubMed ID: 23187833
[TBL] [Abstract][Full Text] [Related]
18. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and risk factors of pancreatic cancer.
Capasso M; Franceschi M; Rodriguez-Castro KI; Crafa P; Cambiè G; Miraglia C; Barchi A; Nouvenne A; Leandro G; Meschi T; De' Angelis GL; Di Mario F
Acta Biomed; 2018 Dec; 89(9-S):141-146. PubMed ID: 30561407
[TBL] [Abstract][Full Text] [Related]
20. Advances in pancreatic cancer research: moving towards early detection.
He XY; Yuan YZ
World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
